BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 32111794)

  • 1. Distribution of Regulatory T-Cells and Other Phenotypes of T-Cells in Tumors and Regional Lymph Nodes of Colorectal Cancer Patients.
    Kazama K; Otake J; Satoyoshi T; Shiozawa M; Sugano N; Sato S; Atsumi Y; Kano K; Murakawa M; Maezawa Y; Hashimoto I; Numata M; Oshima T; Yukawa N; Rino Y; Sasada T; Masuda M
    In Vivo; 2020; 34(2):849-856. PubMed ID: 32111794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of a CD4
    Jafarinia M; Mehdipour F; Hosseini SV; Ghahramani L; Hosseinzadeh M; Ghaderi A
    Tumour Biol; 2016 Nov; 37(11):14659-14666. PubMed ID: 27619682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area.
    Heeren AM; de Boer E; Bleeker MC; Musters RJ; Buist MR; Kenter GG; de Gruijl TD; Jordanova ES
    Oncotarget; 2015 Oct; 6(32):32484-93. PubMed ID: 26431490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell subpopulations in lymph nodes may not be predictive of patient outcome in colorectal cancer.
    Kemp RA; Black MA; McCall J; Yoon HS; Phillips V; Anjomshoaa A; Reeve AE
    J Exp Clin Cancer Res; 2011 Aug; 30(1):78. PubMed ID: 21864372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
    Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
    J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients.
    Deng L; Zhang H; Luan Y; Zhang J; Xing Q; Dong S; Wu X; Liu M; Wang S
    Clin Cancer Res; 2010 Aug; 16(16):4105-12. PubMed ID: 20682706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
    Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC
    J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.
    Alonso-Álvarez S; Vidriales MB; Caballero MD; Blanco O; Puig N; Martin A; Peñarrubia MJ; Zato E; Galende J; Bárez A; Alcoceba M; Orfão A; González M; García-Sanz R
    Leuk Lymphoma; 2017 May; 58(5):1144-1152. PubMed ID: 27733075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Characters and Plasticity of the Sentinel Lymph Node in Colorectal Cancer Patients.
    Li X; Tang J; Du H; Wang X; Wu L; Hu P; Zhang H; Zhang R; Yang Y
    J Immunol Res; 2021; 2021():5516399. PubMed ID: 34458377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal cancer induces a regulatory lymphocytic phenotype in the tumor-draining lymph nodes to promote cancer cell installation.
    Giatromanolaki A; Koukourakis IM; Chatzipantelis P; Kouroupi M; Balaska K; Koukourakis MI
    Immunol Res; 2020 Dec; 68(6):363-372. PubMed ID: 33150567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry CD4(+)CD26(-)CD38(+) lymphocyte subset in the microenvironment of Hodgkin lymphoma-affected lymph nodes.
    Di Gaetano R; Gasparetto V; Padoan A; Callegari B; Candiotto L; Sanzari MC; Scapinello A; Tagariello G
    Ann Hematol; 2014 Aug; 93(8):1319-26. PubMed ID: 24627194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma.
    Tang Y; Xu X; Guo S; Zhang C; Tang Y; Tian Y; Ni B; Lu B; Wang H
    PLoS One; 2014; 9(3):e91551. PubMed ID: 24637664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer.
    Inamori K; Togashi Y; Fukuoka S; Akagi K; Ogasawara K; Irie T; Motooka D; Kobayashi Y; Sugiyama D; Kojima M; Shiiya N; Nakamura S; Maruyama S; Suzuki Y; Ito M; Nishikawa H
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33755600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status.
    Glajcar A; Szpor J; Hodorowicz-Zaniewska D; Tyrak KE; Okoń K
    Virchows Arch; 2019 Jul; 475(1):13-23. PubMed ID: 31016433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
    Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
    Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4
    Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E
    Front Immunol; 2019; 10():2936. PubMed ID: 31921188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
    Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
    Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell subsets and colorectal cancer: discerning the good from the bad.
    Scurr M; Gallimore A; Godkin A
    Cell Immunol; 2012 Sep; 279(1):21-4. PubMed ID: 23041206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node.
    Gai XD; Song Y; Li C; Lei YM; Yang B
    Pathol Res Pract; 2013 Dec; 209(12):774-8. PubMed ID: 24080284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.